IntelliPharmaCeutics International Inc. Stock OTC Bulletin Board
Equities
CA4581733090
Pharmaceuticals
Financials (USD)
Sales 2021 | - | Sales 2022 | 65.73K | Capitalization | 2.47M |
---|---|---|---|---|---|
Net income 2021 | -5M | Net income 2022 | -2M | EV / Sales 2021 | - |
Net Debt 2021 | 1.15M | Net Debt 2022 | 2.24M | EV / Sales 2022 | 71.6 x |
P/E ratio 2021 |
-0.65
x | P/E ratio 2022 |
-0.85
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.24% |
Managers | Title | Age | Since |
---|---|---|---|
Amina Odidi
FOU | Founder | - | 97-12-31 |
Isa Odidi
CEO | Chief Executive Officer | - | 97-12-31 |
Comptroller/Controller/Auditor | - | 07-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Norman Betts
BRD | Director/Board Member | 69 | 19-01-21 |
Isa Odidi
CEO | Chief Executive Officer | - | 97-12-31 |
Amina Odidi
FOU | Founder | - | 97-12-31 |
1st Jan change | Capi. | |
---|---|---|
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |